HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/4/L1002    most recent 00161.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Shimoda, L. A. Articles by Swenson, E. R. Search for Related Content PubMed PubMed Citation Articles by Shimoda, L. A. Articles by Swenson, E. R.

Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition

¹Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland; ²Department of Chemistry, University of California at Berkeley, Berkeley, California; and ³Division of Pulmonary and Critical Care Medicine, University of Washington School of Medicine, St. Louis, Missouri

Submitted 25 April 2006 ; accepted in final form 13 December 2006

Hypoxic pulmonary vasoconstriction (HPV) occurs with ascent to high altitude and can contribute to development of high altitude pulmonary edema (HAPE). Vascular smooth muscle contains carbonic anhydrase (CA), and acetazolamide (AZ), a CA inhibitor, blunts HPV and might be useful in the prevention of HAPE. The mechanism by which AZ impairs HPV is uncertain. Originally developed as a diuretic, AZ also has direct effects on systemic vascular smooth muscle, including modulation of pH and membrane potential; however, the effect of AZ on pulmonary arterial smooth muscle cells (PASMCs) is unknown. Since HPV requires Ca²⁺ influx into PASMCs and can be modulated by pH, we hypothesized that AZ alters hypoxia-induced changes in PASMC intracellular pH (pH_i) or Ca²⁺ concentration ([Ca²⁺]_i). Using fluorescent microscopy, we tested the effect of AZ as well as two other potent CA inhibitors, benzolamide and ethoxzolamide, which exhibit low and high membrane permeability, respectively, on hypoxia-induced responses in PASMCs. Hypoxia caused a significant increase in [Ca²⁺]_i but no change in pH_i. All three CA inhibitors slightly decreased basal pH_i, but only AZ caused a concentration-dependent decrease in the [Ca²⁺]_i response to hypoxia. AZ had no effect on the KCl-induced increase in [Ca²⁺]_i or membrane potential. N-methyl-AZ, a synthesized compound lacking the unsubstituted sulfonamide group required for CA inhibition, had no effect on pH_i but inhibited hypoxia-induced Ca²⁺ responses. These results suggest that AZ attenuates HPV by selectively inhibiting hypoxia-induced Ca²⁺ responses via a mechanism independent of CA inhibition, changes in pH_i, or membrane potential.

pulmonary vascular smooth muscle; intracellular Ca²⁺

This article has been cited by other articles:

				M. S. Torring, K. Holmgaard, A. Hessellund, C. Aalkjaer, and T. Bek The Vasodilating Effect of Acetazolamide and Dorzolamide Involves Mechanisms Other Than Carbonic Anhydrase Inhibition Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 345 - 351. [Abstract] [Full Text] [PDF]

				J.-P. Richalet, M. Rivera-Ch, M. Maignan, C. Privat, I. Pham, J.-L. Macarlupu, O. Petitjean, and F. Leon-Velarde Acetazolamide for Monge's Disease: Efficiency and Tolerance of 6-Month Treatment Am. J. Respir. Crit. Care Med., June 15, 2008; 177(12): 1370 - 1376. [Abstract] [Full Text] [PDF]

				V. Faoro, S. Huez, S. Giltaire, A. Pavelescu, A. van Osta, J.-J. Moraine, H. Guenard, J.-B. Martinot, and R. Naeije Effects of acetazolamide on aerobic exercise capacity and pulmonary hemodynamics at high altitudes J Appl Physiol, October 1, 2007; 103(4): 1161 - 1165. [Abstract] [Full Text] [PDF]